For dosing we really don't know exactly when that would have ended. For tracking mortality the protocol says up to two years. The FDA itself would have required Cytodyn to track mortality and SAEs after the end of dosing for quite some time so we should have that data by now. Although we might not have had it at the time of the last conference call.